the heading of the article is below ...interestingHow PharmAust is offering hope to patients with MND and ALS using veterinary drug monepantel
The head of PharmAust says the Perth biotech could offer hope to the hundreds of thousands of patients with motor neurone disease and ALS using a re-purposed veterinary drug approved for sheep drench.
The clinical-stage company completed a phase 1 study in December, with the recent findings revealing the drug monepantel — typically used to remove worm infestations in sheep — reduced the progression of the neuro degenerative diseases by 58 per cent.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.015(6.25%) |
Mkt cap ! $109.4M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 22.5¢ | $133.9K | 573.8K |
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 303213 | 22.5¢ |
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 57592 | 2 |
| Last trade - 15.46pm 18/10/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |
